This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Are These Stocks Bargains Before Earnings?
by Shaun Pruitt
Next week's earnings lineup features quite a few stocks that appear to trade at discounts considering their affordable price tags and fundamental metrics.
Is a Surprise Coming for Herbalife (HLF) This Earnings Season?
by Zacks Equity Research
Herbalife (HLF) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Will Herbalife LTD. (HLF) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Herbalife LTD. (HLF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Covenant Logistics and Herbalife have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Covenant Logistics and Herbalife are part of the Zacks Bull and Bear of the Day article.
Bear Of The Day: Herbalife (HLF)
by Brian Bolan
Is Bill Ackman getting the last laugh in on this infamous battle ground stock?
Herbalife LTD. (HLF) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 22.97% and 0.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Herbalife LTD. (HLF) Q3 Earnings Expected to Decline
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Walgreens Boots Alliance (WBA) Beats Q4 Earnings Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 2.56% and 0.13%, respectively, for the quarter ended August 2022. Do the numbers hold clues to what lies ahead for the stock?
Herbalife LTD. (HLF) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 52.38% and 7.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate CVS Health (CVS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Herbalife LTD. (HLF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Herbalife LTD. (HLF) Soars 15.2%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Herbalife LTD. (HLF) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Herbalife LTD. (HLF) Q1 Earnings Beat Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 13.79% and 2.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Rite Aid (RAD) Stock Jumps 7.4%: Will It Continue to Soar?
by Zacks Equity Research
Rite Aid (RAD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Herbalife LTD. (HLF) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of -3.39% and 3.74%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CVS Health (CVS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 2.06% and 0.79%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Is Herbalife (HLF) a Worthy Stock for Value Investors?
by Zacks Equity Research
Is Herbalife (HLF) a great pick from the value investor's perspective right now? Read on to know more.
Herbalife LTD. (HLF) Q3 Earnings Top Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 15.24% and -1.29%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Herbalife LTD. (HLF) Q3 Earnings Expected to Decline
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for October 5th
by Zacks Equity Research
BABA, BBBY, DAN, AVO, and HLF have been added to the Zacks Rank #5 (Strong Sell) List on October 5, 2021.
Company News for Sep 15, 2021
by Zacks Equity Research
Companies in The News Are: FCEL,ORCL,AVO,HLF
Here's Why Herbalife LTD. (HLF) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Herbalife LTD. (HLF) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 20.63% and 0.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Herbalife LTD. (HLF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon